Recent Updates
Recently added Catalysts
LLY Neutral Sentiment

Lilly to Participate in UBS Biopharma Conference 2023 Eli Lilly and Company (NYSE: LLY) will attend the UBS Biopharma Conference on Nov. 8, 2023. Patrik Jonsson, executive vice president; president,...

Thursday, October 26, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Eli Lilly and Company (NYSE: LLY) is scheduled to participate in the UBS Biopharma Conference on November 8, 2023. Patrik Jonsson, the executive vice president, will lead a fireside chat during the event. Investors can access a live audio webcast of the chat, along with a replay available for approximately 90 days on Lilly's Investor website. The event underscores Lilly's commitment to open communication with stakeholders.
Price reaction · baseline $586.46 (2023-10-25 close) · hit after-hours · clean, no other LLY news in the window
day 0 close · peak
-3.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Eli Lilly will present at a notable Biopharma conference.
  • The participation highlights Lilly's ongoing engagement with investors.
  • Lilly provides a live audio webcast for transparency.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+45%
120-day peak, hindsight
Typical move
2%
average across 15 past catalysts
Lead asset
Dulaglutide
Phase 3 · Type 2 Diabetes Mellitus

Full Press Release Details

INDIANAPOLIS , Oct. 26, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) will attend the UBS Biopharma Conference on Nov. 8 , 2023. Patrik Jonsson, executive vice president; president, Lilly Immunology; president, Lilly USA ; and chief customer officer, will participate in a fireside chat at 3 p.m., Eastern time .
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at https://investor.lilly.com/webcasts-and-presentations . A replay of the presentation will be available on this same website for approximately 90 days.
Refer to: Jordan Bishop; [email protected] ; 317-473-5712 (Media)
Joe Fletcher; [email protected] ; 317-296-2884 (Investors)

Frequently Asked Questions

When will Eli Lilly participate in the UBS Biopharma Conference?

Eli Lilly will participate in the UBS Biopharma Conference on Nov. 8, 2023.

Who will represent Eli Lilly at the conference?

Patrik Jonsson, the executive vice president, will represent Eli Lilly.

How can I watch the event live?

The event can be watched via live audio webcast on Lilly's Investor website.

Will there be a replay of the conference?

Yes, a replay will be available on the website for about 90 days.

What time is Eli Lilly's fireside chat scheduled?

The fireside chat is scheduled for 3 p.m. Eastern time.

ShareAdd on Google
Tags: LLY Viatris Investor Conferences Healthcare Eli Lilly NYUSE: LLY UBS Conference biopharma investor webcast
Last updated: Oct 26, 2023

Biotech snapshot

Cash runway
$8950M liquidity · $0M/mo burn
Low dilution risk
Lead asset
DulaglutidePhase 3
Type 2 Diabetes Mellitus →

Catalyst track record

+45%
best trade around LLY's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for LLY.

See every catalyst's timing & PoA →